Tomohiro Saito

500 total citations
29 papers, 364 citations indexed

About

Tomohiro Saito is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Tomohiro Saito has authored 29 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Tomohiro Saito's work include Parathyroid Disorders and Treatments (10 papers), Bone health and treatments (4 papers) and Autoimmune Bullous Skin Diseases (2 papers). Tomohiro Saito is often cited by papers focused on Parathyroid Disorders and Treatments (10 papers), Bone health and treatments (4 papers) and Autoimmune Bullous Skin Diseases (2 papers). Tomohiro Saito collaborates with scholars based in Japan and United States. Tomohiro Saito's co-authors include Taihei Suzuki, Ken Iseri, Yukihiro Wada, Masayuki Iyoda, Takanori Shibata, Kei Matsumoto, Hirohisa Saito, Katsuaki Sato, Yasutaka Yamamoto and Masahiko Nakagawa and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Tomohiro Saito

26 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomohiro Saito Japan 11 166 69 59 55 40 29 364
Smith United States 9 27 0.2× 72 1.0× 19 0.3× 200 3.6× 16 0.4× 29 559
Guillaume Courbon United States 13 139 0.8× 30 0.4× 36 0.6× 185 3.4× 62 1.6× 22 554
Stéphane Blouin Austria 20 81 0.5× 42 0.6× 69 1.2× 259 4.7× 218 5.5× 78 921
Satoshi Yamada Japan 12 18 0.1× 55 0.8× 11 0.2× 149 2.7× 30 0.8× 55 433
Robert A. Woodbury United States 8 32 0.2× 45 0.7× 31 0.5× 131 2.4× 36 0.9× 14 479
Laura S. Gregory Australia 14 13 0.1× 45 0.7× 26 0.4× 182 3.3× 81 2.0× 35 717
A Takagi Japan 9 50 0.3× 235 3.4× 31 0.5× 227 4.1× 8 0.2× 32 569
Shigeru Soshi Japan 11 15 0.1× 23 0.3× 96 1.6× 141 2.6× 91 2.3× 22 632
Arnaud Vanden‐Bossche France 19 35 0.2× 32 0.5× 24 0.4× 287 5.2× 122 3.0× 32 735
Michelle L. Key United Kingdom 8 23 0.1× 33 0.5× 12 0.2× 175 3.2× 194 4.8× 9 502

Countries citing papers authored by Tomohiro Saito

Since Specialization
Citations

This map shows the geographic impact of Tomohiro Saito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohiro Saito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohiro Saito more than expected).

Fields of papers citing papers by Tomohiro Saito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohiro Saito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohiro Saito. The network helps show where Tomohiro Saito may publish in the future.

Co-authorship network of co-authors of Tomohiro Saito

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohiro Saito. A scholar is included among the top collaborators of Tomohiro Saito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohiro Saito. Tomohiro Saito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saito, Tomohiro, Tadashi Kato, Noriyuki Kato, et al.. (2025). Phosphate binder pill burden and cardiovascular events in patients undergoing hemodialysis. Therapeutic Apheresis and Dialysis. 29(3). 333–344.
2.
Saito, Tomohiro, et al.. (2025). Associations of roxadustat with copper elevation and hypothyroidism in patients on hemodialysis. International Urology and Nephrology. 58(2). 681–690.
3.
Kato, Tadashi, Kazuki Kobayashi, Tomohiro Saito, et al.. (2025). PTH variability is associated with increased risk of mortality in Japanese hemodialysis patients. Clinical and Experimental Nephrology. 30(1). 135–144.
4.
Saito, Tomohiro, Masahide Mizobuchi, Tadashi Kato, et al.. (2023). Fibroblast Growth Factor 23 Exacerbates Cardiac Fibrosis in Deoxycorticosterone Acetate-Salt Mice With Hypertension. Laboratory Investigation. 103(1). 100003–100003. 4 indexed citations
5.
Saito, Tomohiro, et al.. (2023). Changes of biomarkers for erythropoiesis, iron metabolism, and FGF23 by supplementation with roxadustat in patients on hemodialysis. Scientific Reports. 13(1). 3181–3181. 3 indexed citations
6.
Saito, Tomohiro, Masahide Mizobuchi, Takehisa Kawata, et al.. (2023). Effects of evocalcet on parathyroid calcium‐sensing receptor and vitamin D receptor expression in uremic rats. The FASEB Journal. 37(8). e23094–e23094. 1 indexed citations
7.
Saito, Tomohiro, Masahide Mizobuchi, Tadashi Kato, et al.. (2022). One-Year Romosozumab Treatment Followed by One-Year Denosumab Treatment for Osteoporosis in Patients on Hemodialysis: An Observational Study. Calcified Tissue International. 112(1). 34–44. 24 indexed citations
8.
Saito, Tomohiro, Masahide Mizobuchi, Yusuke Miwa, et al.. (2020). Anti‐MDA‐5 antibody‐positive clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease treated with therapeutic plasma exchange: A case series. Journal of Clinical Apheresis. 36(1). 196–205. 16 indexed citations
9.
Saito, Tomohiro, et al.. (2019). Multidisciplinary management of calciphylaxis: a series of 5 patients at a single facility. CEN Case Reports. 9(2). 122–128. 6 indexed citations
10.
Wada, Yukihiro, Kei Matsumoto, Taihei Suzuki, et al.. (2018). Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy. PLoS ONE. 13(11). e0206865–e0206865. 52 indexed citations
11.
Yamamoto, Yasutaka, Masayuki Iyoda, Kei Matsumoto, et al.. (2017). Erlotinib attenuates the progression of chronic kidney disease in rats with remnant kidney. Nephrology Dialysis Transplantation. 33(4). 598–606. 17 indexed citations
12.
Iyoda, Masayuki, Ken Iseri, Tomohiro Saito, et al.. (2016). Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy. PLoS ONE. 11(6). e0158154–e0158154. 48 indexed citations
13.
Wada, Yukihiro, Masayuki Iyoda, Tomohiro Saito, et al.. (2015). Light-Chain Deposition Disease Successfully Treated with Bortezomib in an Elderly Patient: A Case Report and Review of the Literature. Internal Medicine. 54(22). 2893–2898. 5 indexed citations
14.
Wada, Yukihiro, Masayuki Iyoda, Kei Matsumoto, et al.. (2014). Epidermal Growth Factor Receptor Inhibition with Erlotinib Partially Prevents Cisplatin-Induced Nephrotoxicity in Rats. PLoS ONE. 9(11). e111728–e111728. 29 indexed citations
15.
Saito, Tomohiro, et al.. (2011). [Clinical evaluation of the new creatine kinase MB reagent kit "L-System CK-MB MtO"].. PubMed. 59(3). 236–42. 4 indexed citations
16.
Saito, Tomohiro, et al.. (1992). A Case of Intraluminal Duodenal Diverticulum with Duodenal Stenosis Caused by Adult Annular Pancreas.. The Japanese Journal of Gastroenterological Surgery. 25(7). 2018–2022. 1 indexed citations
17.
Yasui, Takahiro, et al.. (1991). [Clinical application of chemotherapy via the portal vein with liposome-encapsulated adriamycin in inoperable metastatic liver cancer].. PubMed. 18(11). 1878–83. 1 indexed citations
18.
Saito, Tomohiro, et al.. (1989). Lymphatic subpopulations and their transition in myocardial tissue and peripheral blood of patients with biopsy-proven myocarditis.. Japanese Circulation Journal. 53(1). 1–6. 3 indexed citations
19.
Saito, Tomohiro, Katsuaki Sato, & Hirohisa Saito. (1986). An experimental study of auditory dysfunction associated with hyperlipoproteinemia. European Archives of Oto-Rhino-Laryngology. 243(4). 242–245. 45 indexed citations
20.
Shiraishi, Satomi, Yasushi Ohkubo, & Tomohiro Saito. (1979). Regression of multiple osseous metastatic renal cell carcinoma.. PubMed. 246–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Smith Breakdown of academic impact, for papers by Guillaume Courbon Breakdown of academic impact, for papers by Stéphane Blouin Breakdown of academic impact, for papers by Satoshi Yamada Breakdown of academic impact, for papers by Robert A. Woodbury Breakdown of academic impact, for papers by Laura S. Gregory Breakdown of academic impact, for papers by A Takagi Breakdown of academic impact, for papers by Shigeru Soshi Breakdown of academic impact, for papers by Arnaud Vanden‐Bossche Breakdown of academic impact, for papers by Michelle L. Key
Rankless by CCL
2026